未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry study日本肺癌患者中静脉血栓栓塞症的发病率和临床特征：CS-Lung-003前瞻性观察性登记研究的结果
Tsubata, Yukari; Kanaji, Nobuhiro; Nakao, Mika; Masuda, Takeshi; Yamasaki, Masahiro; Kodani, Masahiro; Ishikawa, Nobuhisa; Kozuki, Toshiyuki; Inoue, Masaaki; Nishii, Kazuya; Hotta, Katsuyuki; Kiura, Katsuyuki; Isobe, Takeshi 分享 收藏 分享 收藏 Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study吉非替尼诱导联合化放疗在EGFR突变型III期非小细胞肺癌中的五年结果：LOGIK0902/OLCSG0905 II期研究Hotta, Katsuyuki; Saeki, Sho; Sakata, Shinya; Yamaguchi, Masafumi; Harada, Daijiro; Bessho, Akihiro; Tanaka, Kentaro; Inoue, Koji; Inoue, Koji; Gemba, Kenichi; Kubo, Toshio; Sato, Akiko; Ichihara, Eiki; Watanabe, Hiromi; Kishimoto, Junji; Shioyama, Yoshiyuki; Katsui, Kuniaki; Sugio, Kenji; Kiura, Katsuyuki 分享 收藏 Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer血浆S100A8/A9水平预测晚期非小细胞肺癌患者对免疫检查点抑制剂的反应Kuribayashi, Tadahiro; Kinoshita, Rie; Ninomiya, Kiichiro; Makimoto, Go; Kubo, Toshio; Rai, Kammei; Ichihara, Eiki; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki; Toyooka, Shinichi; Sakaguchi, Masakiyo; Ohashi, Kadoaki 分享 收藏 A novel molecular target, superoxide dismutase 1, in ALK inhibitor-resistant lung cancer cells, detected through proteomic analysis通过蛋白质组学分析在ALK抑制剂耐药的肺癌细胞中检测到一个新的分子靶标，超氧化物歧化酶1Miyake, Noriko; Ochi, Nobuaki; Takeyama, Masami; Isozaki, Hideko; Ichihara, Eiki; Yamane, Hiromichi; Fukazawa, Takuya; Nagasaki, Yasunari; Kawahara, Tatsuyuki; Nakanishi, Hidekazu; Hiraki, Akio; Kiura, Katsuyuki; Takigawa, Nagio 分享 收藏 Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Cancer Database表皮生长因子受体-酪氨酸激酶抑制剂对伴有表皮生长因子受体突变的转移性非小细胞肺癌患者的疗效: 来自日本癌症数据库的发现Okuma, Yusuke; Shintani, Yasushi; Sekine, Ikuo; Shukuya, Takehito; Takayama, Koichi; Inoue, Akira; Okamoto, Isamu; Kiura, Katsuyuki; Yamamoto, Nobuyuki; Kawaguchi, Tomoya; Miyaoka, Etsuo; Yoshino, Ichiro; Date, Hiroshi 分享 收藏 Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancerMorita, Ayako; Ichihara, Eiki; Inoue, Koji; Fujiwara, Keiichi; Yokoyama, Toshihide; Harada, Daijiro; Ando, Chihiro; Kano, Hirohisa; Oda, Naohiro; Tamura, Tomoki; Ochi, Nobuaki; Kawai, Haruyuki; Inoue, Masaaki; Hara, Naofumi; Fujimoto, Nobukazu; Ichikawa, Hirohisa; Oze, Isao; Hotta, Katsuyuki; Maeda, Yoshinobu; Kiura, Katsuyuki 分享 收藏 A NOVEL MOLECULAR TARGET, SUPEROXIDE DISMUTASE 1, IN ALK INHIBITOR-RESISTANT LUNG CANCER, DETECTED THROUGH PROTEOMIC ANALYSISTakigawa, Nagio; Miyake, Noriko; Ochi, Nobuaki; Takeyama, Masami; Isozaki, Hideko; Ichihara, Eiki; Nakanishi, Hidekazu; Yamane, Hiromichi; Kiura, Katsuyuki 分享 收藏 Phase-Ib trial of metformin combined with nivolumab for refractory/recurrent solid tumorsKubo, T.; Kato, H.; Horiguchi, S.; Ninomiya, T.; Kozuki, T.; Asagi, A.; Takamoto, A.; Umeda, Y.; Kamikawa, K.; Yoshida, M.; Udono, U.; Hotta, K.; Maeda, Y.; Kiura, K. 分享 收藏 CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancerHara, Naofumi; Ichihara, Eiki; Kano, Hirohisa; Ando, Chihiro; Morita, Ayako; Nishi, Tatsuya; Okawa, Sachi; Nakasuka, Takamasa; Hirabae, Atsuko; Abe, Masaya; Asada, Noboru; Ninomiya, Kiichiro; Makimoto, Go; Fujii, Masanori; Kubo, Toshio; Ohashi, Kadoaki; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki 分享 收藏 Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies接受癌症免疫疗法治疗的晚期NSCLC患者颅内进展的低频率Kemmotsu, Naoya; Ninomiya, Kiichiro; Kunimasa, Kei; Ishino, Takamasa; Nagasaki, Joji; Otani, Yoshihiro; Michiue, Hiroyuki; Ichihara, Eiki; Ohashi, Kadoaki; Inoue, Takako; Tamiya, Motohiro; Sakai, Kazuko; Ueda, Youki; Dansako, Hiromichi; Nishio, Kazuto; Kiura, Katsuyuki; Date, Isao; Togashi, Yosuke 分享 收藏 Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective StudyHigo, Hisao; Ichikawa, Hirohisa; Arakawa, Yukako; Mori, Yoshihiro; Itano, Junko; Taniguchi, Akihiko; Senoo, Satoru; Kimura, Goro; Tanimoto, Yasushi; Miyake, Kohei; Katsuta, Tomoya; Kataoka, Mikio; Maeda, Yoshinobu; Kiura, Katsuyuki; Miyahara, Nobuaki 分享 收藏 Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study流行病学，危险因素和恶病质对患者预后的影响: 来自日本肺癌注册研究的结果Shukuya, Takehito; Takahashi, Kazuhisa; Shintani, Yasushi; Miura, Keita; Sekine, Ikuo; Takayama, Koichi; Inoue, Akira; Okamoto, Isamu; Kiura, Katsuyuki; Kawaguchi, Tomoya; Yamamoto, Nobuyuki; Miyaoka, Etsuo; Yoshino, Ichiro; Date, Hiroshi 分享 收藏 Neuropeptide Y Antagonizes Development of Pulmonary Fibrosis through IL-1β InhibitionItano, Junko; Taniguchi, Akihiko; Senoo, Satoru; Asada, Noboru; Gion, Yuka; Egusa, Yuria; Guo, Lili; Oda, Naohiro; Araki, Kota; Sato, Yasuharu; Toyooka, Shinichi; Kiura, Katsuyuki; Maeda, Yoshinobu; Miyahara, Nobuaki 分享 收藏 Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study (vol 6, 100191, 2021)Hotta, K.; Saeki, S.; Yamaguchi, M.; Harada, D.; Bessho, A.; Tanaka, K.; Inoue, K.; Gemba, K.; Shiojiri, M.; Kato, Y.; Ninomiya, T.; Kubo, T.; Kishimoto, J.; Shioyama, Y.; Katsui, K.; Sasaki, J.; Kiura, K.; Sugio, K. 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
CLINICAL LUNG CANCER.png)
OAAI